{‘She possesses no qualifications’: this American healthcare field girds for Høeg's tenure at the Food and Drug Administration.

As the United States undertakes historic revisions to its immunization recommendations, one figure has surfaced unexpectedly: Høeg, a Danish American sports medicine doctor and epidemiologist who initially gained attention by expressing skepticism about Covid vaccinations throughout the global health crisis and has zeroed in on alleged deaths following Covid immunization in her short position at the Food and Drug Administration.

Planned Overhauls to Pediatric Immunization Program

Agency leaders were set to announce sweeping revisions to the pediatric vaccination calendar earlier this month, aligning the US with Denmark’s vaccine program, according to reports – a substantial departure that would put the US out of step with many the world with little proof for improved outcomes. The planned update has been pushed back until the new year.

Instead of Vinay Prasad, Dr. Høeg is scheduled to present at the gathering. She was recently named temporary leader of the FDA’s CDER, the fifth person to head the office this year.

Consolidating Power at the FDA

This interim role might represent a tighter collaboration between the drug and vaccine branches as Høeg and Prasad consolidate power at the regulatory agency – and it signals a increased emphasis upon reevaluating already-approved immunizations at the FDA.

Høeg has often pushed for ending certain childhood vaccine recommendations in the US so as to align more similar to Denmark's approach, a nation with nationalized medicine and a number of inhabitants about the population of the state of Wisconsin.

In her initial statements, she has kept her attention on vaccines – usually the responsibility of Prasad, chief of the FDA’s vaccine center – instead of drug regulation.

Questions Over Expertise

The appointee has no obvious experience in drug development, oversight or management, which has been customary for previous directors of the biologics center. She has served at the FDA as a key advisor to the FDA chief and the vaccine center since March.

“It seems she lacks to have the requisite experience” for running the pharmaceutical oversight division, remarked Dr. Jonathan Howard. “She lacks experience running a clinical trial. She has no expertise in managing a sizeable institution. She lacks background in pharmaceutical oversight.”

Previous heads of the center would “understand regulatory frameworks and the research of drug development”, noted a former acting FDA commissioner. “Objectively, she has not acquired the type of experience that former directors who ran the center have had.”

This division has an vast portfolio at the FDA, she stated.

“The public just pays attention on the innovative therapies, but the off-patent medication office clears a multitude of generic drugs. There’s a biosimilars division, over-the-counter program and so forth, and every single one have to be managed,” Woodcock said. “The thing you neglect, that is precisely what that I always told people is going to cause problems.”

There is also, a substantial management aspect to the role, which supervises over 5,000 staff members. “It’s a massive administrative position, if you perform it correctly,” the former official said.

Agency Reaction and Controversial Initiatives

Regarding inquiries about Dr. Høeg's fitness for the role and whether this appointment signifies greater collaboration among agency officials on vaccines, a representative said that the “inquiries are based on flawed presumptions”.

“This background is consistent with the functions of her position,” the representative stated, pointing to the period Høeg spent advising the agency head on “drug safety and oversight research, including computational safety modeling and immunization monitoring”.

In her interim role, Dr. Høeg takes over the commissioner’s recently launched fast-track approval initiative, a controversial one-day drug-approval program that apparently worried her predecessors. “How are these medications being selected for this expedited pathway? Who is making the decisions?” Dr. Howard asked. “There is a lot of secrecy happening at the agency right now.”

Overall, he stated, “the Food and Drug Administration seems to be moving towards laxer oversight of all drugs, except for shots.”

Public Past Work on Vaccines

With vaccines, Dr. Høeg has a clearer, if problematic, track record, Howard have noted. She authored a research paper using unverified crowd-sourced reports to assess the frequency of heart inflammation after Covid vaccination. She consulted for the state of Florida top health official Joseph Ladapo, who was said to have modified findings to suggest Covid vaccinations are more dangerous than they are.

Part of her “policy goals” for the incoming government encompassed revising regulations for new vaccines and ending “non-essential” vaccines, she said after the election on a audio program. At the agency, Dr. Høeg has according to sources suggested excluding teenage boys from obtaining Covid vaccinations.

“She is an thorough dogmatist who begins with her beliefs and works backwards to fit the science in a highly disingenuous, fraudulent way,” Howard argued.

Consolidating Power and a “Campaign of Retribution”

Dr. Høeg became part of fellow skeptics, {like|